Sites of action of sleep and wake drugs: Insights from model organisms

Current Opinion in Neurobiology

Volumn 23, Issue 5, 2013, Pages 831-840

  Rihel, Jason ^a   Schier, Alexander F ^b,c,d  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b HARVARD UNIVERSITY   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d HARVARD STEM CELL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; ADENOSINE RECEPTOR STIMULATING AGENT; ALFADOLONE; ALMOREXANT; BF 2 649; CAFFEINE; CHLOROPYRAMINE; DOXEPIN; ESZOPICLONE; IIK 7; LORATADINE; MELATONIN; MEPYRAMINE; MODAFINIL; PITOLISANT; RAMELTEON; SUVOREXANT; UCM 765; UNCLASSIFIED DRUG; ZALEPLON; ZOLPIDEM; ZOLPIDEM TARTRATE;

BINDING SITE; BRAIN REGION; DAYTIME SOMNOLENCE; DRUG ACTIVITY; DRUG ANTAGONISM; DRUG MECHANISM; DRUG POTENTIATION; GABAERGIC TRANSMISSION; INSOMNIA; LOW DRUG DOSE; NARCOLEPSY; NERVE CELL; NONHUMAN; NONREM SLEEP; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; SLEEP WAKING CYCLE; WAKEFULNESS;

ANIMALS; BRAIN; HUMANS; SLEEP; WAKEFULNESS;

EID: 84884352145     PISSN: 09594388     EISSN: 18736882     Source Type: Journal    
DOI: 10.1016/j.conb.2013.04.010     Document Type: Review

References (97)

1. Ioachimescu O.C., El-Solh A.A. Pharmacotherapy of insomnia. Expert Opin Pharmacother 2012, 13:1243-1260.
2. Ellenbogen J.M., Pace-Schott E.F. Drug-induced sleep: theoretical and practical considerations. Pflügers Arch 2011, 463:177-186.
3. Rihel J., Prober D.A., Arvanites A., Lam K., Zimmerman S., Jang S., Haggarty S.J., Kokel D., Rubin L.L., Peterson R.T., et al. Zebrafish behavioral profiling links drugs to biological targets and rest/wake regulation. Science 2010, 327:348-351.
4. Rihel J., Schier A.F. Behavioral screening for neuroactive drugs in zebrafish. Dev Neurobiol 2012, 72:373-385.
5. Bushey D., Cirelli C. From genetics to structure to function: exploring sleep in Drosophila. Int Rev Neurobiol 2011, 99:213-244.
6. Rudolph U., Knoflach F. Beyond classical benzodiazepines: novel therapeutic potential of GABAA receptor subtypes. Nat Rev Drug Discov 2011, 10:685-697.
7. McKernan R.M., Rosahl T.W., Reynolds D.S., Sur C., Wafford K.A., Atack J.R., Farrar S., Myers J., Cook G., Ferris P., et al. Sedative but not anxiolytic properties of benzodiazepines are mediated by the GABA(A) receptor alpha1 subtype. Nat Neurosci 2000, 3:587-592.
8. van Rijnsoever C., Täuber M., Choulli M.K., Keist R., Rudolph U., Mohler H., Fritschy J.M., Crestani F. Requirement of alpha5-GABAA receptors for the development of tolerance to the sedative action of diazepam in mice. J Neurosci 2004, 24:6785-6790.
9. Tan K.R., Brown M., Labouèbe G., Yvon C., Creton C., Fritschy J.-M., Rudolph U., Lüscher C. Neural bases for addictive properties of benzodiazepines. Nature 2010, 463:769-774.
10. Zecharia A.Y., Yu X., Gotz T., Ye Z., Carr D.R., Wulff P., Bettler B., Vyssotski A.L., Brickley S.G., Franks N.P., et al. GABAergic inhibition of histaminergic neurons regulates active waking but not the sleep-wake switch or propofol-induced loss of consciousness. J Neurosci 2012, 32:13062-13075.
11. Heldt S.A., Ressler K.J. Amygdala-specific reduction of alpha1-GABAA receptors disrupts the anticonvulsant, locomotor, and sedative, but not anxiolytic, effects of benzodiazepines in mice. J Neurosci 2010, 30:7139-7151.
12. Kumar S., Alam M.N., Rai S., Bashir T., McGinty D., Szymusiak R. Central nervous system sites of the sleep promoting effects of eszopiclone in rats. Neuroscience 2011, 181:67-78.
13. Moore J.T., Chen J., Han B., Meng Q.C., Veasey S.C., Beck S.G., Kelz M.B. Direct activation of sleep-promoting VLPO neurons by volatile anesthetics contributes to anesthetic hypnosis. Curr Biol 2012, 22:2008-2016.
14. Kottler B., Bao H., Zalucki O., Imlach W., Troup M., Van Alphen B., Paulk A., Zhang B., Van Swinderen B. A sleep/wake circuit controls isoflurane sensitivity in Drosophila. Curr Biol 2013, 10.1016/j.cub.2013.02.021.
15. Agosto J., Choi J.C., Parisky K.M., Stilwell G., Rosbash M., Griffith L.C. Modulation of GABAA receptor desensitization uncouples sleep onset and maintenance in Drosophila. Nat Neurosci 2008, 11:354-359.
16. Parisky K.M., Agosto J., Pulver S.R., Shang Y., Kuklin E., Hodge J.J.L., Kang K., Liu X., Garrity P.A., Rosbash M., et al. PDF cells are a GABA-responsive wake-promoting component of the Drosophila sleep circuit. Neuron 2008, 60:672-682.
17. Chung B.Y., Kilman V.L., Keath J.R., Pitman J.L., Allada R. The GABAA receptor RDL acts in peptidergic PDF neurons to promote sleep in Drosophila. Curr Biol 2009, 19:386-390.
18. Sullivan S. Update on emerging drugs for insomnia. Expert Opin Emerg Drugs 2012, 17:295-298.
19. Krystal A.D., Richelson E., Roth T. Review of the histamine system and the clinical effects of H(1) antagonists: basis for a new model for understanding the effects of insomnia medications. Sleep Med Rev 2013, 10.1016/j.smrv.2012.08.001.
20. Huang Z.-L., Mochizuki T., Qu W.-M., Hong Z.-Y., Watanabe T., Urade Y., Hayaishi O. Altered sleep-wake characteristics and lack of arousal response to H3 receptor antagonist in histamine H1 receptor knockout mice. Proc Natl Acad Sci U S A 2006, 103:4687-4692.
21. Unno K., Ozaki T., Mohammad S., Tsuno S., Ikeda-Sagara M., Honda K., Ikeda M. First and second generation H1 histamine receptor antagonists produce different sleep-inducing profiles in rats. Eur J Pharmacol 2012, 683:179-185.
22. Stahl S.M. Selective histamine H1 antagonism: novel hypnotic and pharmacologic actions challenge classical notions of antihistamines. CNS Spectr 2008, 13:1027-1038.
23. Ramesh V., Thakkar M.M., Strecker R.E., Basheer R., McCarley R.W. Wakefulness-inducing effects of histamine in the basal forebrain of freely moving rats. Behav Brain Res 2004, 152:271-278.
24. Lin J.S., Hou Y., Sakai K., Jouvet M. Histaminergic descending inputs to the mesopontine tegmentum and their role in the control of cortical activation and wakefulness in the cat. J Neurosci 1996, 16:1523-1537.
25. Sundvik M., Kudo H., Toivonen P., Rozov S., Chen Y.-C., Panula P. The histaminergic system regulates wakefulness and orexin/hypocretin neuron development via histamine receptor H1 in zebrafish. FASEB J 2011, 25:4338-4347.
26. Sundvik M., Panula P. Organization of the histaminergic system in adult zebrafish (Danio rerio) brain: neuron number, location, and cotransmitters. J Comp Neurol 2012, 520:3827-3845.
27. 3 receptor antagonists in rats. Behav Brain Res 2012, 232:416-420.
28. Gondard E., Anaclet C., Akaoka H., Guo R.-X., Zhang M., Buda C., Franco P., Kotani H., Lin J.-S. Enhanced histaminergic neurotransmission and sleep-wake alterations, a study in histamine H3-receptor knock-out mice. Neuropsychopharmacology 2013, 10.1038/npp.2012.266.
29. Lin J.-S., Sergeeva O.A., Haas H.L. Histamine H3 receptors and sleep-wake regulation. J Pharmacol Exp Ther 2011, 336:17-23.
30. Krueger J.M. The role of cytokines in sleep regulation. Curr Pharm Des 2008, 14:3408-3416.
31. Urade Y., Hayaishi O. Prostaglandin D2 and sleep/wake regulation. Sleep Med Rev 2011, 15:411-418.
32. Bjorness T.E., Greene R.W. Adenosine and sleep. Curr Neuropharmacol 2009, 7:238-245.
33. Halassa M.M., Florian C., Fellin T., Munoz J.R., Lee S.-Y., Abel T., Haydon P.G., Frank M.G. Astrocytic modulation of sleep homeostasis and cognitive consequences of sleep loss. Neuron 2009, 61:213-219.
34. Porkka-Heiskanen T., Strecker R.E., McCarley R.W. Brain site-specificity of extracellular adenosine concentration changes during sleep deprivation and spontaneous sleep: an in vivo microdialysis study. Neuroscience 2000, 99:507-517.
35. Brown R.E., Basheer R., McKenna J.T., Strecker R.E., McCarley R.W. Control of sleep and wakefulness. Physiol Rev 2012, 92:1087-1187.
36. Hawryluk J.M., Ferrari L.L., Keating S.A., Arrigoni E. Adenosine inhibits glutamatergic input to basal forebrain cholinergic neurons. J Neurophysiol 2012, 107:2769-2781.
37. Thakkar M.M., Winston S., McCarley R.W. A1 receptor and adenosinergic homeostatic regulation of sleep-wakefulness: effects of antisense to the A1 receptor in the cholinergic basal forebrain. J Neurosci 2003, 23:4278-4287.
38. Rai S., Kumar S., Alam M.A., Szymusiak R., McGinty D., Alam M.N. A1 receptor mediated adenosinergic regulation of perifornical-lateral hypothalamic area neurons in freely behaving rats. Neuroscience 2010, 167:40-48.
39. Oishi Y., Huang Z.-L., Fredholm B.B., Urade Y., Hayaishi O. Adenosine in the tuberomammillary nucleus inhibits the histaminergic system via A1 receptors and promotes non-rapid eye movement sleep. Proc Natl Acad Sci U S A 2008, 105:19992-19997.
40. Gallopin T., Luppi P.-H., Cauli B., Urade Y., Rossier J., Hayaishi O., Lambolez B., Fort P. The endogenous somnogen adenosine excites a subset of sleep-promoting neurons via A2A receptors in the ventrolateral preoptic nucleus. Neuroscience 2005, 134:1377-1390.
41. Methippara M.M., Kumar S., Alam M.N., Szymusiak R., McGinty D. Effects on sleep of microdialysis of adenosine A1 and A2a receptor analogs into the lateral preoptic area of rats. Am J Physiol Regul Integr Comp Physiol 2005, 289:R1715-R1723.
42. Scammell T.E., Gerashchenko D.Y., Mochizuki T., McCarthy M.T., Estabrooke I.V., Sears C.A., Saper C.B., Urade Y., Hayaishi O. An adenosine A2a agonist increases sleep and induces Fos in ventrolateral preoptic neurons. Neuroscience 2001, 107:653-663.
43. Huang Z.-L., Qu W.-M., Eguchi N., Chen J.-F., Schwarzschild M.A., Fredholm B.B., Urade Y., Hayaishi O. Adenosine A2A, but not A1, receptors mediate the arousal effect of caffeine. Nat Neurosci 2005, 8:858-859.
44. Lazarus M., Shen H.-Y., Cherasse Y., Qu W.-M., Huang Z.-L., Bass C.E., Winsky-Sommerer R., Semba K., Fredholm B.B., Boison D., et al. Arousal effect of caffeine depends on adenosine A2A receptors in the shell of the nucleus accumbens. J Neurosci 2011, 31:10067-10075.
45. Lazarus M., Huang Z.-L., Lu J., Urade Y., Chen J.-F. How do the basal ganglia regulate sleep-wake behavior?. Trends Neurosci 2012, 35:723-732.
46. Wu M.N., Ho K., Crocker A., Yue Z., Koh K., Sehgal A. The effects of caffeine on sleep in Drosophila require PKA activity, but not the adenosine receptor. J Neurosci 2009, 29:11029-11037.
47. Wisor J.P., Nishino S., Sora I., Uhl G.H., Mignot E., Edgar D.M. Dopaminergic role in stimulant-induced wakefulness. J Neurosci 2001, 21:1787-1794.
48. Qu W.-M., Huang Z.-L., Xu X.-H., Matsumoto N., Urade Y. Dopaminergic D1 and D2 receptors are essential for the arousal effect of modafinil. J Neurosci 2008, 28:8462-8469.
49. Young J.W., Kooistra K., Geyer M.A. Dopamine receptor mediation of the exploratory/hyperactivity effects of modafinil. Neuropsychopharmacology 2011, 36:1385-1396.
50. Madras B.K., Xie Z., Lin Z., Jassen A., Panas H., Lynch L., Johnson R., Livni E., Spencer T.J., Bonab A.A., et al. Modafinil occupies dopamine and norepinephrine transporters in vivo and modulates the transporters and trace amine activity in vitro. J Pharmacol Exp Ther 2006, 319:561-569.
51. Volkow N.D., Fowler J.S., Logan J., Alexoff D., Zhu W., Telang F., Wang G.-J., Jayne M., Hooker J.M., Wong C., et al. Effects of modafinil on dopamine and dopamine transporters in the male human brain: clinical implications. JAMA 2009, 301:1148-1154.
52. Andersen M.L., Kessler E., Murnane K.S., McClung J.C., Tufik S., Howell L.L. Dopamine transporter-related effects of modafinil in rhesus monkeys. Psychopharmacology (Berl) 2010, 210:439-448.
53. Schmitt K.C., Reith M.E.A. The atypical stimulant and nootropic modafinil interacts with the dopamine transporter in a different manner than classical cocaine-like inhibitors. PLoS ONE 2011, 6:e25790.
54. Kume K., Kume S., Park S.K., Hirsh J., Jackson F.R. Dopamine is a regulator of arousal in the fruit fly. J Neurosci 2005, 25:7377-7384.
55. Wu M.N., Koh K., Yue Z., Joiner W.J., Sehgal A. A genetic screen for sleep and circadian mutants reveals mechanisms underlying regulation of sleep in Drosophila. Sleep 2008, 31:465-472.
56. Lebestky T., Chang J.-S.C., Dankert H., Zelnik L., Kim Y.-C., Han K.-A., Wolf F.W., Perona P., Anderson D.J. Two different forms of arousal in Drosophila are oppositely regulated by the dopamine D1 receptor ortholog DopR via distinct neural circuits. Neuron 2009, 64:522-536.
57. Stavropoulos N., Young M.W. Insomniac and Cullin-3 regulate sleep and wakefulness in Drosophila. Neuron 2011, 72:964-976.
58. Pfeiffenberger C., Allada R. Cul3 and the BTB adaptor insomniac are key regulators of sleep homeostasis and a dopamine arousal pathway in Drosophila. PLoS Genet. 2012, 8:e1003003.
59. Shang Y., Haynes P., Pírez N., Harrington K.I., Guo F., Pollack J., Hong P., Griffith L.C., Rosbash M. Imaging analysis of clock neurons reveals light buffers the wake-promoting effect of dopamine. Nat Neurosci 2011, 14:889-895.
60. Ueno T., Tomita J., Tanimoto H., Endo K., Ito K., Kume S., Kume K. Identification of a dopamine pathway that regulates sleep and arousal in Drosophila. Nat Neurosci 2012, 15:1516-1523.
61. Liu Q., Liu S., Kodama L., Driscoll M.R., Wu M.N. Two dopaminergic neurons signal to the dorsal fan-shaped body to promote wakefulness in Drosophila. Curr Biol 2012, 22:2114-2123.
62. Donlea J.M., Thimgan M.S., Suzuki Y., Gottschalk L., Shaw P.J. Inducing sleep by remote control facilitates memory consolidation in Drosophila. Science 2011, 332:1571-1576.
63. Sigurgeirsson B., Thorsteinsson H., Arnardóttir H., Jóhannesdóttir I.T., Karlsson K.A. Effects of modafinil on sleep-wake cycles in larval zebrafish. Zebrafish 2011, 8:133-140.
64. Fisher S.P., Sugden D. Endogenous melatonin is not obligatory for the regulation of the rat sleep-wake cycle. Sleep 2010, 33:833-840.
65. Zhdanova I.V. Melatonin as a hypnotic: pro. Sleep Med Rev 2005, 9:51-65.
66. Van den Heuvel C.J., Ferguson S.A., Macchi M.M., Dawson D. Melatonin as a hypnotic: con. Sleep Med Rev 2005, 9:71-80.
67. Comai S., Ochoa-Sanchez R., Gobbi G. Sleep-wake characterization of double MT(1)/MT(2) receptor knockout mice and comparison with MT(1) and MT(2) receptor knockout mice. Behav Brain Res 2013, 243C:231-238.
68. Fisher S.P., Sugden D. Sleep-promoting action of IIK7, a selective MT2 melatonin receptor agonist in the rat. Neurosci Lett 2009, 457:93-96.
69. Ochoa-Sanchez R., Comai S., Lacoste B., Bambico F.R., Dominguez-Lopez S., Spadoni G., Rivara S., Bedini A., Angeloni D., Fraschini F., et al. Promotion of non-rapid eye movement sleep and activation of reticular thalamic neurons by a novel MT2 melatonin receptor ligand. J Neurosci 2011, 31:18439-18452.
70. Pandi-Perumal S.R., Trakht I., Srinivasan V., Spence D.W., Maestroni G.J.M., Zisapel N., Cardinali D.P. Physiological effects of melatonin: role of melatonin receptors and signal transduction pathways. Prog Neurobiol 2008, 85:335-353.
71. Pevet P., Challet E. Melatonin: both master clock output and internal time-giver in the circadian clocks network. J Physiol-Paris 2011, 105:170-182.
72. Zhdanova I.V., Wang S.Y., Leclair O.U., Danilova N.P. Melatonin promotes sleep-like state in zebrafish. Brain Res 2001, 903:263-268.
73. Appelbaum L., Wang G.X., Maro G.S., Mori R., Tovin A., Marin W., Yokogawa T., Kawakami K., Smith S.J., Gothilf Y., et al. Sleep-wake regulation and hypocretin-melatonin interaction in zebrafish. Proc Natl Acad Sci U S A 2009, 106:21942-21947.
74. Prober D.A., Rihel J., Onah A.A., Sung R.-J., Schier A.F. Hypocretin/orexin overexpression induces an insomnia-like phenotype in zebrafish. J Neurosci 2006, 26:13400-13410.
75. Naumann E.A., Kampff A.R., Prober D.A., Schier A.F., Engert F. Monitoring neural activity with bioluminescence during natural behavior. Nat Neurosci 2010, 13:513-520.
76. Elbaz I., Yelin-Bekerman L., Nicenboim J., Vatine G., Appelbaum L. Genetic ablation of hypocretin neurons alters behavioral state transitions in zebrafish. J Neurosci 2012, 32:12961-12972.
77. Brisbare-Roch C., Dingemanse J., Koberstein R., Hoever P., Aissaoui H., Flores S., Mueller C., Nayler O., Van Gerven J., De Haas S.L., et al. Promotion of sleep by targeting the orexin system in rats, dogs and humans. Nat Med 2007, 13:150-155.
78. Cox C.D., Breslin M.J., Whitman D.B., Schreier J.D., McGaughey G.B., Bogusky M.J., Roecker A.J., Mercer S.P., Bednar R.A., Lemaire W., et al. Discovery of the dual orexin receptor antagonist [(7R)-4-(5-chloro-1,3-benzoxazol-2-yl)-7-methyl-1,4-diazepan-1-yl][5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl]methanone (MK-4305) for the treatment of insomnia. J Med Chem 2010, 53:5320-5332.
79. Sun H., Kennedy W.P., Wilbraham D., Lewis N., Calder N., Li X., Ma J., Yee K.L., Ermlich S., Mangin E., et al. Effects of suvorexant, an orexin receptor antagonist, on sleep parameters as measured by polysomnography in healthy men. Sleep 2013, 36:259-267.
80. Herring W.J., Snyder E., Budd K., Hutzelmann J., Snavely D., Liu K., Lines C., Roth T., Michelson D. Orexin receptor antagonism for treatment of insomnia: a randomized clinical trial of suvorexant. Neurology 2012, 79:2265-2274.
81. Willie J.T., Chemelli R.M., Sinton C.M., Tokita S., Williams S.C., Kisanuki Y.Y., Marcus J.N., Lee C., Elmquist J.K., Kohlmeier K.A., et al. Distinct narcolepsy syndromes in orexin receptor-2 and orexin null mice: molecular genetic dissection of non-REM and REM sleep regulatory processes. Neuron 2003, 38:715-730.
82. Mieda M., Hasegawa E., Kisanuki Y.Y., Sinton C.M., Yanagisawa M., Sakurai T. Differential roles of orexin receptor-1 and -2 in the regulation of non-REM and REM sleep. J Neurosci 2011, 31:6518-6526.
83. Mang G.M., Dürst T., Bürki H., Imobersteg S., Abramowski D., Schuepbach E., Hoyer D., Fendt M., Gee C.E. The dual orexin receptor antagonist almorexant induces sleep and decreases orexin-induced locomotion by blocking orexin 2 receptors. Sleep 2012, 35:1625-1635.
84. Morairty S.R., Revel F.G., Malherbe P., Moreau J.-L., Valladao D., Wettstein J.G., Kilduff T.S., Borroni E. Dual hypocretin receptor antagonism is more effective for sleep promotion than antagonism of either receptor alone. PLoS ONE 2012, 7:e39131.
85. Gozzi A., Turrini G., Piccoli L., Massagrande M., Amantini D., Antolini M., Martinelli P., Cesari N., Montanari D., Tessari M., et al. Functional magnetic resonance imaging reveals different neural substrates for the effects of orexin-1 and orexin-2 receptor antagonists. PLoS ONE 2011, 6:e16406.
86. Mochizuki T., Arrigoni E., Marcus J.N., Clark E.L., Yamamoto M., Honer M., Borroni E., Lowell B.B., Elmquist J.K., Scammell T.E. Orexin receptor 2 expression in the posterior hypothalamus rescues sleepiness in narcoleptic mice. Proc Natl Acad Sci U S A 2011, 108:4471-4476.
87. Liu M., Blanco-Centurion C., Konadhode R., Begum S., Pelluru D., Gerashchenko D., Sakurai T., Yanagisawa M., Van den Pol A.N., Shiromani P.J. Orexin gene transfer into zona incerta neurons suppresses muscle paralysis in narcoleptic mice. J Neurosci 2011, 31:6028-6040.
88. Blanco-Centurion C., Liu M., Konadhode R., Pelluru D., Shiromani P.J. Effects of orexin gene transfer in the dorsolateral pons in orexin knockout mice. Sleep 2013, 36:31-40.
89. Lee M.G., Hassani O.K., Jones B.E. Discharge of identified orexin/hypocretin neurons across the sleep-waking cycle. J Neurosci 2005, 25:6716-6720.
90. Adamantidis A.R., Zhang F., Aravanis A.M., Deisseroth K., De Lecea L. Neural substrates of awakening probed with optogenetic control of hypocretin neurons. Nature 2007, 450:420-424.
91. Carter M.E., Yizhar O., Chikahisa S., Nguyen H., Adamantidis A., Nishino S., Deisseroth K., De Lecea L. Tuning arousal with optogenetic modulation of locus coeruleus neurons. Nat Neurosci 2010, 13:1526-1533.
92. Carter M.E., Brill J., Bonnavion P., Huguenard J.R., Huerta R., De Lecea L. Mechanism for hypocretin-mediated sleep-to-wake transitions. PNAS 2012, 109:E2635-E2644.
93. Carter M.E., Adamantidis A., Ohtsu H., Deisseroth K., De Lecea L. Sleep homeostasis modulates hypocretin-mediated sleep-to-wake transitions. J Neurosci 2009, 29:10939-10949.
94. Ellis L.D., Seibert J., Soanes K.H. Distinct models of induced hyperactivity in zebrafish larvae. Brain Res 2012, 1449:46-59.
95. Ahrens M.B., Li J.M., Orger M.B., Robson D.N., Schier A.F., Engert F., Portugues R. Brain-wide neuronal dynamics during motor adaptation in zebrafish. Nature 2012, 485:471-477.
96. Orger M.B., Kampff A.R., Severi K.E., Bollmann J.H., Engert F. Control of visually guided behavior by distinct populations of spinal projection neurons. Nat Neurosci 2008, 11:327-333.
97. Del Bene F., Wyart C. Optogenetics: a new enlightenment age for zebrafish neurobiology. Dev Neurobiol 2012, 72:404-414.